Increased plasma kynurenine and its relationship to neopterin and tryptophan in Tourette's syndrome

Psychological Medicine

Volumn 26, Issue 4, 1996, Pages 857-862

  Rickards, H ^a   Dursun, S M ^b   Farrar, G ^b   Betts, T ^b   Corbett, J A ^b   Handley, S L ^b  

^a UNIVERSITY OF BIRMINGHAM   (United Kingdom)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

KYNURENINE; NEOPTERIN; TRYPTOPHAN;

ADOLESCENT; ADULT; ARTICLE; BLOOD LEVEL; CELLULAR IMMUNITY; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GILLES DE LA TOURETTE SYNDROME; HUMAN; MALE; NORMAL HUMAN; SCHOOL CHILD;

EID: 0030037840     PISSN: 00332917     EISSN: None     Source Type: Journal    
DOI: 10.1017/s0033291700037880     Document Type: Article

References (29)

1. Bender, D. A., Njagi, E. N. M. & Danielian, P. S. (1991). Comparison of tryptophan metabolism in vivo and in isolated hepatocytes from vitamin B6 deficient mice. Advances in Experimental Medicine and Biology 294, 359-368.
2. Brett, P. M., Curtis, D., Robertson, M. M. & Gurling, H. (1995) Exclusion of the 5HT1A serotonin neuroreceptor and tryptophan oxygenase in Gilles de la Tourette syndrome. American Journal of Psychiatry 152, 437-441.
3. Comings, D. E. (1990). Blood serotonin and tryptophan in Tourette syndrome. American Journal of Medical Genetics 36, 418-430.
4. Coppen, A., Brooksbank, B. W. L., Eccleston, E., Peet, M. & White, S. G. (1974). Tryptophan metabolism in depressive illness. Psychological Medicine 4, 164-173.
5. Curzon, G. & Bridge, P. K. (1970). Tryptophan metabolism in depression. Journal of Neurology and Neurosurgery and Psychiatry 33, 698-704.
6. Eapen, V., Pauls, D. L. & Robertson, M. M. (1993). Evidence for autosomal dominant transmission in Tourette's Syndrome United Kingdom cohort study. British Journal of Psychiatry 162, 593-596.
7. Fraser, A., Ghanshyam, N. P. & Mendels, J. (1973). Metabolism of tryptophan in depressive disease. Archives of General Psychiatry 29, 528-535.
8. Haber, S. N. & Wolfer, D. (1992). Basal ganglia peptidergic staining in Tourette's syndrome. Advances in Neurology 58, 145-150.
9. Handley, S. L. & Dursun, S. M. (1992). Serotonin and Tourette's syndrome: movements such as head-shakes and wet-dog-shakes may model human tics. Advances in Biosciences 85, 235-253.
10. Handley, S. L. & Miskin, R. C. (1977). The interaction of some kynurenine pathway metabolites with 5-hydroxytryptophan and 5-hydroxytryptamine. Psychopharmacology 51, 305-309.
11. Heyes, M. P. (1992). Metabolism and neuropathological significance of quinolinic acid and kynurenic acid. Biochemical Society Transactions 21, 83-89.
12. Joseph, M. H. & Risby, D. (1975). The determination of kynurenine in plasma Clinica Chimica Acta 63, 197-204.
13. Joseph, M. H., Baker, H. F., Crow, T. J., Riley, G. J. & Risby, D. (1979). Brain tryptophan metabolism in Schizophrenia: a post-mortem study of metabolites of the serotonin and kynurenine pathways in schizophrenic and control subjects. Psychopharmacology 62, 279-285.
14. Knox, W. E. (1953). The relation of liver kynureninase to tryptophan metabolism in pyridoxine deficiency. Biochemical Journal 53, 379-385.
15. Orlikov, A. B., Prakh'e, I. B. & Ryzhov, I. V. (1990). Plasma kynurenine levels and the dexamethasone suppression test in patients with endogenous anxiety disorders and depression (Russian). Zhurnal Nevropatologii i Psikhiatrii Imeni S-S-Korsakova 90, 83-85.
16. Riddle, M. A., Rasmusson, A. M., Woods, S. W. & Hoffer, P. B. (1992). SPECT imaging of cerebral blood flow in Tourette syndrome. Advances in Neurology 58, 207-211.
17. Rubin, R. (1967). Adrenal cortical activity changes in manic depressive illness. Archives of General Psychiatry 17, 671-679.
18. Statistical Package for Social Sciences (1992). SPSS: Chicago.
19. Schimke, R. T., Sweeney, E. W. & Berlin, C. M. (1965). The roles of synthesis and degradation in the control of liver tryptophan pyrrolase. Journal of Biological Chemistry 240, 322-331.
20. Schwarz, R. (1993). Metabolism and function of brain kynurenines. Biochemical Society Transactions 21, 77-82.
21. Singer, H. S., Reiss, A. L., Brown, J. E., Aylward, E. H., Shih, B., Chee, E., Harris, E. L., Reader, M. J., Chase, G. A., Bryan, R. N. & Denkla, M. B. (1993). Volumetric changes in basal ganglia of children with Tourette's syndrome. Neurology 43, 171-175.
22. Takaiwa, P., Habara-Ohkubo, A. & Yoshida, R. (1991). Induction of indoleamine 2,3-dioxygenase in tumor cells transplanted into allogeneic mouse: interferon-gamma is the inducer. Advances in Experimental Medicine and Biology 294, 437-446.
23. Wachter, H., Fuchs, D., Hausen, A., Reibnegger, G., Weiss, G., Werner, E. R. & Werner-Felmayer, G. (1992). Neopterin. Walter de Gruyter: Berlin.
24. Werner, E. R., Kauffmann, M. H., Fuchs, D., Hausen, A., Reibnegger, G., Schweiger, M. & Wachter, H. (1987). Interferon-gamma induced degradation of tryptophan by human cells in vitro. Biological Chemistry Hoppe-Seyler 368, 1407-1412.
25. Werner, E. R., Werner-Felmayer, G., Fuchs, D., Hausen, A., Reibnegger, G. & Wachter, H. (1988). Influence of interferon-gamma and extracellular tryptophan on indoleamine 2,3-dioxygenase activity in T24 cells as determined by a nonradiometric assay. Biochemical Journal 256, 537-541.
26. Werner, E. R., Werner-Felmayer, G., Fuchs, D., Hausen, A., Reibnegger, G. & Wachter, H. (1989). Parallel induction of tetrahydrobiopterin biosynthesis and indoleamine 2,3-dioxygenase activity in human cells and cell lines. Biochemical Journal 262, 861-866.
27. Wood, K., Harwood, J. & Coppen, A. (1978). The effect of antidepressant drugs on plasma kynurenine in depressed patients. Psychopharmacology 59, 263-266.
28. Wurtman, R. J. (1979). When- and why- should nutritional state control neurotransmitter synthesis? Journal of Neural Transmission Suppl. 15, 69-79.
29. Yamazaki, F., Kuroiwa, T., Takikawa, T. & Kido, R. (1985). Human indoleamine 2,3-dioxygenase, its tissue distribution, and characterization of the placental enzyme. Biochemical Journal 230, 635-638.